Mevion Medical Systems is announcing that the Mevion S250 proton therapy system at the Stephenson Cancer Center at the University of Oklahoma has completed its rigorous acceptance testing and is now entering the clinical commissioning phase. Clinical commissioning is the final step before physicians begin treating patients with the system.


A University of California-Davis study found that half of primary care physicians are still unfamiliar with a controversial state law mandating that radiologists tell women if they have dense breast tissue.


The 2014 Best in KLAS report ranks healthcare vendors and their solutions by the professionals who use them—healthcare providers.

FlexAbility Ablation Catheter

Fujifilm SonoSite, Inc. and The Floating Doctors, a nonprofit organization dedicated to promoting improvements in healthcare delivery worldwide, announced the release of the first video in a series titled “Bridging the Gap.” 

VuComp Inc. announced that two additional patents have been issued to the company, extending its intellectual property related to computer-aided detection of breast cancer.

Elekta announced its latest research and development initiatives, with special focus on Atlantic, a high field MRI-guided radiation therapy system. 

The silence is deafening. And since radiology associations, physician groups and vendors have yet to publicly respond to the elephant in the room, I offer the following in hopes we can get the conversation started...

Death rates from lung cancer will exceed those for breast cancer for the first time among European women in 2015, according to the latest predictions published in the cancer journal Annals of Oncology.

Subscribe Now